Download Files:
Ilunocitinib
$310 – $2,400
Products Details
Product Description
– Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1].
Web ID
– HY-132819
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C17H17N7O2S
References
– [1]James D. Rodgers, et al. Azetidine and cyclobutane derivatives as jak inhibitors. Patent. WO2009114512A1.
CAS Number
– 1187594-14-4
Molecular Weight
– 383.43
Compound Purity
– 98.01
SMILES
– N#CCC1(CN(S(=O)(C2CC2)=O)C1)N3N=CC(C4=C5C=CNC5=NC=N4)=C3
Clinical Information
– No Development Reported
Research Area
– Others
Solubility
– DMSO : 250 mg/mL (ultrasonic)
Target
– JAK
Pathway
– Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
